XRTX - XORTX Announces Participation in Spring 2024 Investor Conferences | Benzinga

CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANUA WKN: A3UNZ)), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that Dr. Allen Davidoff, CEO, is scheduled to participate in the following Spring 2024 investor and life sciences investment conferences:

• LD Micro Invitational XIV in New York, April 8-9
  Management will deliver a corporate update on April 9^th at 2:00 p.m. ET and will be available for one-on-one meetings.
  Registration link:

• Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference, April 17-18
  Management will deliver a virtual presentation and will be available for virtual one-on-one meetings.
  Registration Link:

• Full story available on Benzinga.com